BOM:532305 (India)
Â
Shs Dematerialised
₹
106.78
(-1.99%)
Dec 26
Business Description
Ind-Swift Laboratories Ltd
ISIN : INE915B01019
Share Class Description:
BOM:532305: Shs DematerialisedCompare
Compare
Traded in other countries / regions
532305.India IPO Date
2000-09-18Description
Ind-Swift Laboratories Ltd is engaged in the business of manufacturing Active Pharmaceutical Ingredients (API), Intermediates, and formulations. The company caters to diverse therapeutic segments namely Cardiovascular health, Antihistamine, Antidiabetic, Antipsychotic, Parkinson's Disease, Antineoplastic, ADHD Symptoms, Analgesics, Alcohol Abstinence, and Bone Resorption Inhibitor. It operates in a single segment namely, Bulk Drugs and Pharmaceuticals. Geographically, the company caters to both Indian and international markets, of which, maximum revenue is derived from outside India.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 26.74 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.03 | |||||
| Interest Coverage | 16.36 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.63 | |||||
| Beneish M-Score | 3.66 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12.8 | |||||
| 3-Year EBITDA Growth Rate | 50.8 | |||||
| 3-Year Book Growth Rate | 15.6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.24 | |||||
| 9-Day RSI | 45.16 | |||||
| 14-Day RSI | 46.54 | |||||
| 6-1 Month Momentum % | -19.82 | |||||
| 12-1 Month Momentum % | -0.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.57 | |||||
| Quick Ratio | 3.51 | |||||
| Cash Ratio | 2.67 | |||||
| Days Inventory | 114.25 | |||||
| Days Sales Outstanding | 124.06 | |||||
| Days Payable | 79.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 128.97 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 32.36 | |||||
| Operating Margin % | 12.96 | |||||
| Net Margin % | 51.44 | |||||
| FCF Margin % | -28.6 | |||||
| ROE % | 41.9 | |||||
| ROA % | 26.98 | |||||
| ROIC % | 7.25 | |||||
| ROC (Joel Greenblatt) % | 105.03 | |||||
| ROCE % | 45.17 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 1.69 | |||||
| PE Ratio without NRI | 6.88 | |||||
| PEG Ratio | 0.37 | |||||
| PS Ratio | 0.87 | |||||
| PB Ratio | 0.63 | |||||
| Price-to-Tangible-Book | 0.62 | |||||
| EV-to-EBIT | 0.41 | |||||
| EV-to-EBITDA | 0.39 | |||||
| EV-to-Revenue | 0.29 | |||||
| EV-to-FCF | -1.01 | |||||
| Price-to-Projected-FCF | 0.47 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.37 | |||||
| Price-to-Graham-Number | 0.44 | |||||
| Price-to-Net-Current-Asset-Value | 1.54 | |||||
| Price-to-Net-Cash | 2.41 | |||||
| Earnings Yield (Greenblatt) % | 245.45 | |||||
| FCF Yield % | -32.91 | |||||
| Forward Rate of Return (Yacktman) % | 25.36 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ind-Swift Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 7,259.725 | ||
| EPS (TTM) (₹) | 63.2 | ||
| Beta | 1.45 | ||
| Volatility % | 57.41 | ||
| 14-Day RSI | 46.54 | ||
| 14-Day ATR (₹) | 3.19779 | ||
| 20-Day SMA (₹) | 107.5715 | ||
| 12-1 Month Momentum % | -0.02 | ||
| 52-Week Range (₹) | 87 - 186 | ||
| Shares Outstanding (Mil) | 59.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ind-Swift Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ind-Swift Laboratories Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ind-Swift Laboratories Ltd Frequently Asked Questions
What is Ind-Swift Laboratories Ltd(BOM:532305)'s stock price today?
The current price of BOM:532305 is ₹106.78. The 52 week high of BOM:532305 is ₹186.00 and 52 week low is ₹87.00.
When is next earnings date of Ind-Swift Laboratories Ltd(BOM:532305)?
The next earnings date of Ind-Swift Laboratories Ltd(BOM:532305) is .
Does Ind-Swift Laboratories Ltd(BOM:532305) pay dividends? If so, how much?
Ind-Swift Laboratories Ltd(BOM:532305) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers